I am a board-certified medical oncologist and physician-scientist who specializes in caring for people with hematologic malignancies, including acute and chronic leukemias, myelodysplastic syndromes, and myeloproliferative neoplasms.
Read more Read less
I currently spend the majority of my time performing laboratory-based research with the central aim of developing and investigating the mechanisms of action of novel leukemia-directed epigenetic therapies. My hope is that these research efforts will ultimately result in a deeper understanding of how leukemias develop as well as improved clinical outcomes for our patients.
- Clinical Expertise: Acute and Chronic Leukemias; Myelodysplastic Syndrome
- Awards and Honors: Leukemia and Lymphoma Society Career Development Program Fellow Award (2016); American Society of Clinical Oncology Young Investigator Award (2016)
- Languages Spoken: English
- Education: MD, PhD, Washington University School of Medicine in St. Louis
- Residencies: NewYork-Presbyterian/Weill Cornell Medicine
- Fellowships: Memorial Sloan Kettering Cancer Center
- Board Certifications: Internal Medicine; Medical Oncology
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more